Early Development Still Driving CRO Performance

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2004, Volume 28, Issue 9

Early development services continue to be a sweet spot for contract R&D services. The big question is how soon the impact of early-development candidates will be felt in late development and commercialization.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookContract Manufacturing, GeneralPharmaceutical Technology-09-02-2004
With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs
Roche Forms Partnership Worth Potentially More than $1 Billion with Innovent to Develop Novel ADC for SCLC
Creating a Sustainable Approach